Rules for identifying potentially reactive or promiscuous compounds.
暂无分享,去创建一个
[1] Stefan Vasile,et al. The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase alpha is mediated by hydrogen peroxide. , 2004, Archives of biochemistry and biophysics.
[2] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[3] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[4] Brian Hudson,et al. Strategic Pooling of Compounds for High-Throughput Screening , 1999, J. Chem. Inf. Comput. Sci..
[5] M. Waring,et al. Complex formation between ethidium bromide and nucleic acids. , 1965, Journal of molecular biology.
[6] S Omura,et al. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. , 1977, The Journal of antibiotics.
[7] B. Shoichet. Screening in a spirit haunted world. , 2006, Drug discovery today.
[8] B. Brodie,et al. Absorption of drugs from the stomach. II. The human. , 1957, The Journal of pharmacology and experimental therapeutics.
[9] Tudor I. Oprea,et al. Is There a Difference Between Leads and Drugs? A Historical Perspective. , 2001 .
[10] B. Jastorff,et al. Structure–activity relationships of pyrithiones – IPC-81 toxicity tests with the antifouling biocide zinc pyrithione and structural analogs , 2004 .
[11] T. Schirmeister,et al. Cysteine Proteases and Their Inhibitors , 2010 .
[12] S. Thrall,et al. A Simple Assay for Detection of Small-Molecule Redox Activity , 2007, Journal of biomolecular screening.
[13] T. Ali-vehmas,et al. Automation of the resazurin reduction test using fluorometry of microtitration trays. , 1991, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.
[14] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[15] B. Shoichet,et al. A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.
[16] G. Rishton,et al. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. , 2008, Current opinion in chemical biology.
[17] James Inglese,et al. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.
[18] Michael S Lajiness,et al. Assessment of the consistency of medicinal chemists in reviewing sets of compounds. , 2004, Journal of medicinal chemistry.
[19] Brian K Shoichet,et al. Kinase inhibitors: not just for kinases anymore. , 2003, Journal of medicinal chemistry.
[20] B. Shoichet,et al. High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.
[21] Maria Paola Costi,et al. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. , 2008, Journal of medicinal chemistry.
[22] E. Thorsett,et al. A series of C-Terminal amino alcohol dipeptide Aβ inhibitors , 2002 .
[23] J. Baell. Observations on screening-based research and some concerning trends in the literature. , 2010, Future medicinal chemistry.
[24] Wolfgang Guba,et al. Can we discover pharmacological promiscuity early in the drug discovery process? , 2012, Drug discovery today.
[25] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[26] Andrew C. Good,et al. An Empirical Process for the Design of High-Throughput Screening Deck Filters. , 2006 .
[27] H. Verheij,et al. Leadlikeness and structural diversity of synthetic screening libraries , 2006, Molecular Diversity.
[28] J. Powers,et al. Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases , 2003 .
[29] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[30] C. Chung,et al. Effect of detergent on "promiscuous" inhibitors. , 2003, Journal of medicinal chemistry.
[31] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[32] Anthony M Giannetti,et al. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. , 2008, Journal of medicinal chemistry.